GenePOC: One of Cincinnati's largest public company's closes on $50M acquisition

Meridian Bioscience of Greater Cincinnati has completed its previously announced $50 million acquisition of GenePoc Inc., a Canadian provider of molecular diagnostic instruments and assays. Newtown-based Meridian (NASDAQ: VIVO) previously said it would pay cash for the business of GenePoc, which is based in Quebec City and generated total revenues of less than $1 million in calendar 2018. Meridian agreed to future payments of up to an additional $70 million contingent upon the successful achievement...